Excalipoint Therapeutics
Develops next-generation T-cell engager therapies for cancer and autoimmune diseases
$27.7MSeed+
Role not disclosedLoading investors…
Activity from announced rounds
Develops next-generation T-cell engager therapies for cancer and autoimmune diseases